Study details
Enrolling now
Clinical Trial of Endoscopically Guided Injection of Exparel (Bupivacaine) for Craniofacial Pain
Stanford University
NCT IDNCT04930887ClinicalTrials.gov data as of Apr 2026
Phase
Phase 2
Target enrollment
15
Study length
about 7.4 years
Ages
18–80
Locations
1 site in CA
What this study is about
Researchers are testing whether endoscopically-guided injection of Exparel (Bupivacaine) can help treat craniofacial pain. The trial will involve a treatment with Exparel or saline, and it's designed to see if this approach provides relief compared to the usual topical application of Lidocaine.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Take Exparel (Bupivacaine Liposome)
- 2.Take Saline
Participation Burden
What's physically and logistically required of participants.
Logistics & Travel
In-person visits
Requires travel to a study site
Physical Intervention
Injection / IV
How treatment is administered
Treatment Assignment
All receive treatment
Everyone gets the investigational treatment.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
Drug routes
injection (Injection)
Endpoints
Primary: Change of Pain Score
Secondary: Change of Associated Symptoms
Body systems
Neurology